Anmol India to migrate to BSE main board

The Board of Directors at Anmol India considered and approved the migration of the company listing to the main board of BSE.

Anmol India -HY1-FY21 Net profit jumps to Rs.2.76 crore against Rs.2.41 crore in HY1-FY20

Anmol India – HY1-FY21 Earning per share reached at Rs 2.66 against Rs.2.32 in HY1-FY20

HY2 net profit of Rs.3.25 crore at ANG Life Sciences India in FY19-20

ANG Life Sciences India reports Rs.68.49 crore total revenue in HY2 of FY2019-20 as against Rs.67.51 crore in a year ago period.

Rs.2.84 crore HY1 profit at ANG Life Sciences India in FY19-20

ANG Life Sciences India reported revenue of Rs.58.75 crore for the half year ended 30th September 2019 whereas last year same period it was Rs.54.42 crore.

Profit jumps by 51.61% in FY2018 at ANG Lifesciences

ANG Lifesciences India Ltd earned Rs.45.63 Crore higher revenue in FY2018-19 as compared to last year‘s Rs.76.73 Crore.